Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 13,594 | 12,606 | 13,573 | 13,266 | 14,030 |
| Gross Profit | 13,594 | 12,606 | 13,573 | 13,266 | 14,030 |
| Operating Expenses | 145,928 | 124,564 | 123,660 | 118,796 | 112,331 |
| Operating Income | -132,334 | -111,958 | -110,087 | -105,530 | -98,301 |
| Other Income | 8,653 | 8,832 | -3,320 | -7,699 | -2,377 |
| Pre-tax Income | -123,681 | -103,126 | -113,407 | -113,229 | -100,678 |
| Net Income Continuous | -123,681 | -103,126 | -113,407 | -113,229 | -100,678 |
| Net Income | $-123,681 | $-103,126 | $-113,407 | $-113,229 | $-100,678 |
| EPS Basic Total Ops | -1.40 | -1.17 | -1.38 | -1.49 | -1.33 |
| EPS Basic Continuous Ops | -1.40 | -1.17 | -1.38 | -1.49 | -1.33 |
| EPS Diluted Total Ops | -1.40 | -1.17 | -1.38 | -1.49 | -1.33 |
| EPS Diluted Continuous Ops | -1.40 | -1.17 | -1.38 | -1.49 | -1.33 |
| EPS Diluted Before Non-Recurring Items | -1.40 | -1.17 | -1.40 | N/A | N/A |
| EBITDA(a) | $-130,164 | $-109,908 | $-108,056 | $-103,580 | $-96,464 |